Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on catalytic hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101531628B reveals a scalable one-pot hydrogenation route for 4-dimethylaminopiperidine hydrochloride, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN113801010A reveals a high-yield route for 5-bromo-2-chlorobenzoic acid, a key SGLT2 inhibitor intermediate, offering superior purity and supply chain stability.
Patent CN1356334A details novel Ru-H4-BINAP complexes for efficient ketone reduction, offering high ee values and scalable routes for chiral alcohol intermediates.
Patent CN1356334A reveals novel Ru-H4-BINAP-diamine catalysts enabling high-ee asymmetric hydrogenation of ketones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108033889A reveals a continuous Pd/Al2O3 catalytic method for 2,4-dimethoxyaniline, offering high purity, safety, and significant supply chain cost advantages.
Patent CN101823979B details a zero-emission phenacetin process using reactor-coupled simulated moving bed chromatography for high-purity pharmaceutical intermediates.
Patent CN1252020C details a novel aldol condensation route for cinnamaldehyde derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN101823993A reveals a low-cost, high-yield hydrogenation route for L-octahydroindoline-2-formic acid, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN101823993A reveals a low-cost, high-yield hydrogenation route for L-octahydroindoline-2-carboxylic acid, offering significant supply chain advantages for pharma intermediates.
Patent CN109438538A details a clean 4-AD route for Stanozolol intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN104447509A reveals high-yield Tirofiban hydrochloride process offering significant supply chain stability and cost reduction potential for pharmaceutical manufacturing.
Novel patent CN115028596B enables mild condition synthesis of topramezone intermediate ensuring high purity and supply chain stability for global agrochemical manufacturing.
Advanced asymmetric hydrogenation patent CN103232324B enables cost-effective production of chiral pharmaceutical intermediates with high conversion rates.
Advanced synthesis of diaminomethyl cyclobutane oxalate via FeCl3 catalysis ensures high-purity Lobaplatin intermediates with superior stability and scalable production capabilities.
Patent CN107903182B reveals a high-purity synthesis route for 2-amino-4-acetamino anisole. Discover cost-effective manufacturing and supply chain advantages for dye intermediates.
Novel synthesis route for chlorantraniliprole intermediate ensures high purity and reduced waste for reliable agrochemical intermediate supply chains.
Patent CN107089898B details a green hydrogenation method for biomass phenolics. Discover cost-effective cyclohexanol production for pharmaceutical applications.
Patent CN112441963B details a mild two-step synthesis of bivalent DNJ derivatives, offering high yield and simplified purification for cost-effective API manufacturing.
Patent CN114950452A reveals a novel Co-Y-Ce catalyst for high-purity L-2-aminopropanol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103508908A details a green nitrosation-hydrogenation route for high-purity 4-amino-3-methylphenol, offering significant cost reduction and supply chain reliability for global buyers.